Data Characteristics
Pharmacovigilance data in target discovery originates from preclinical research reports, toxicology data, high-throughput screening results, and public databases. Data update frequency is irregular, typically changing with research progress or database version iterations, for example, quarterly or semi-annually. Document structures vary, including unstructured experimental records, structured biological activity data tables, gene expression profiles, and protein-protein interaction networks. Fields and units are highly specific. Examples include chemical structures (SMILES, InChI), half-maximal inhibitory concentration (IC50, in nM or µM), median lethal dose (LD50, in mg/kg), Gene Ontology (GO) enrichment analysis results, signaling pathway names, organ toxicity scores (e.g., 0-5 scale), and corresponding toxicity descriptions. The data often contains numerous biological entity IDs, such as Entrez Gene ID and UniProt ID.
Constraints Imposed by Data Features on Workflow Orchestration
Data diversity in target discovery presents multiple challenges for workflow orchestration. The presence of unstructured experimental records requires robust text parsing and entity extraction capabilities within the workflow to identify key information such as compounds, genes, and toxicity manifestations. Structured data, like IC50 values, have wide numerical ranges and varying units. This necessitates strict data type validation and unit conversion mechanisms for data standardization and comparison. The uncertain update frequency means workflows cannot rely on fixed time triggers; they should support event-driven triggers based on file uploads or database changes. Cross-referencing of biological entity IDs requires workflows to integrate external knowledge bases for ID mapping and information enrichment. Additionally, the large volume of high-throughput screening results demands high processing performance and concurrency from the workflow to avoid data processing bottlenecks.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 800-1200 characters | Balances semantic completeness of long texts with LLM context window limitations. |
Recall count (Recall Count) | Top 8-12 entries | Balances recall accuracy with computational resource consumption, covering potential related information. |
Similarity threshold (Similarity Threshold) | 0.75-0.85 | Filters out text segments highly relevant to the query, reducing noise. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Accommodates parsing time for large experimental reports or high-throughput data files. |
maxContext | 8192 tokens | Ensures the LLM has sufficient context to process complex biomedical concepts and relationships. |
Rerank result count (Reranked Return Count) | Top 3-5 entries | Further improves the relevance and accuracy of the final output. |
Common Pitfalls
- AI responses include general information unrelated to target discovery. This occurs due to a lack of secondary filtering or reranking of knowledge base recall results, leading to irrelevant information inclusion.
- A tool node in the workflow becomes unresponsive or errors out for an extended period. This may be because the data volume exceeds the tool's design limits, or external API call rates are restricted.
- During workflow testing, the AI fails to correctly identify and compare IC50 units for compounds. This happens when unit information is not precisely extracted during the text parsing stage, or subsequent data processing lacks unit standardization steps.
Verification of Configuration
- For a typical compound or gene, input a query and check if the AI response accurately mentions its known toxicity data and target, providing relevant research report sources.
- Upload a high-throughput screening report containing multiple structures and activities. Observe if the workflow completes parsing within the expected time and extracts key IC50 values and toxicity scores.
- Construct a simulated scenario with identical biological entity IDs named differently. Verify if the workflow successfully performs ID mapping and links them to unified knowledge base information.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.